The Oncogenic Burden of Obesity: Mechanistic Links Between Adiposity and Gastrointestinal Cancers—A Comprehensive Narrative Review
Open Access
- 26 June 2025
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1571
Abstract
Obesity is a global health crisis with profound implications for cancer risk, particularly within the gastrointestinal (GI) tract. Mounting evidence demonstrates that excess adiposity contributes to the initiation, progression, and poor outcomes of GI malignancies through a constellation of interrelated mechanisms. This review comprehensively examines the biologic pathways linking obesity to cancers of the esophagus, stomach, colon, liver, pancreas, and gallbladder. Chronic low-grade inflammation, driven by adipose tissue-derived cytokines and immune cell infiltration, plays a central role in tumorigenesis via the activation of NF-κB, STAT3, and other pro-oncogenic signaling cascades. Hyperinsulinemia and insulin resistance increase mitogenic IGF-1 signaling, while dysregulated adipokines, particularly elevated leptin and reduced adiponectin, promote cellular proliferation and impair tumor suppression. Dysbiosis of the gut microbiome and alterations in bile acid metabolism generate carcinogenic metabolites that contribute to DNA damage and immune evasion. Additionally, obesity-induced tissue hypoxia fosters tumor growth through HIF-1α-mediated pathways. We further highlight organ-specific associations, such as visceral adiposity’s role in Barrett’s esophagus and hepatocellular carcinoma emerging from metabolic dysfunction-associated steatotic liver disease (MASLD). Importantly, emerging data suggest that weight loss, achieved via lifestyle, pharmacologic, or surgical interventions, may mitigate these carcinogenic pathways and improve tumor biology. As obesity prevalence continues to rise globally, elucidating its mechanistic ties to GI malignancies is essential for risk stratification, prevention strategies, and personalized care. By integrating epidemiologic and molecular insights, this review underscores the need for multidisciplinary approaches to curb the oncogenic burden of obesity and improve outcomes in GI oncology.Keywords
This publication has 107 references indexed in Scilit:
- Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decadesCancer Communications, 2025
- Obesity and Gastrointestinal Cancer: A Life Course PerspectiveJAMA Network Open, 2023
- Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapyCancer Communications, 2022
- Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysisInternational Journal of Colorectal Disease, 2021
- Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resectionJournal of Cancer Research and Clinical Oncology, 2021
- The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizingInternational Journal of Cancer, 2019
- Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesisInternational Journal of Cancer, 2017
- Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohortInternational Journal of Cancer, 2012
- Adiponectin and adiponectin receptor in relation to colorectal cancer progressionInternational Journal of Cancer, 2010
- Body mass index and pancreatic cancer risk: A meta‐analysis of prospective studiesInternational Journal of Cancer, 2007